ASEAN Rabies Veterinary Vaccines Market (By Application: Companion Animals, Livestock Animals) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The ASEAN rabies veterinary vaccines market size was estimated at around USD 26.3 million in 2022 and it is projected to hit around USD 45.96 million by 2032, growing at a CAGR of 5.74% from 2023 to 2032.

Report Highlights

• The companion animal segment dominated the market and held a revenue share of over 90.05% in 2022. 
• Thailand accounted for the maximum revenue share of more than 18.03% in 2022.

The market is primarily driven by growing rabies vaccination coverage among dogs in ASEAN countries, rising awareness regarding zoonotic diseases, and increasing government initiatives to eradicate animal and human rabies by the end of 2030.

Appropriate management of the disease in domestic dog populations is essential for the prevention of rabies in humans. The majority of documented rabies cases in both animals and humans of ASEAN countries are caused by dogs. To effectively prevent and control both animal and human rabies, it is vital to raise public awareness regarding the disease while also encouraging responsible pet ownership and animal welfare. Technical and socio-cultural frameworks should both be taken into consideration in a rabies control program. Technical aspects consist of dog population management, vaccination programs, adequate diagnostic capability, disease surveillance programs, and animal movement control. The socio-cultural factors include educating the public and advocating ethical pet ownership and animal welfare.

A framework for collaboration between the FAO, OIE, WHO, and the Global Alliance for Rabies Control (GARC) called "United Against Rabies" has been established for achieving "Zero human rabies deaths by 2030." Along with continuing to urge for stronger actions and involvement in the "United Against Rabies" initiative, ASEAN member states will continue to collaborate with the other partners to prevent human deaths caused by dog-mediated rabies. Several ASEAN member states are facing challenges in achieving the goal set by The ASEAN Rabies Elimination Strategy (ARES) to eradicate rabies. In most ASEAN countries, rabies is still widespread among dogs and rabid dog bites are responsible for almost all human instances of the disease in the region. Vaccination in dogs is considered to be the most affordable method of preventing human rabies.

In ASEAN countries, rabies is a serious public health concern. It has significant adverse effects on human health, the economy, and animal welfare. The primary reservoir and transmitter of rabies in the region are domestic dogs. Lack of funding, a lack of political commitment to rabies control initiatives, a lack of agreement on a strategy, weak intersectoral coordination, insensitive surveillance systems, an inadequate management structure, limited access to modern rabies vaccines, supply issues, a lack of public awareness and cooperation, myths, and religious concerns are all key challenges to rabies control programs. Most ASEAN nations have an endemic canine rabies issue. However, widespread immunization can reduce disease in dog population. The majority of policy and decision-making is done at the national level, therefore developing, and implementing rabies management policies can benefit from a thorough understanding of the costs associated with preventative and control measures with adequate vaccine supply.

Application Insights

The companion animal segment dominated the market and held a revenue share of over 90.05% in 2022. Rabies is spread through saliva, which means the infection can be transmitted through infected animal bites. Although rabies can be transmitted by monkeys, bats, or, in some cases, cats, 98% of rabies cases are reported to be from rabid dog bites. As the rate of dog adoption increased in the past few years, concerns of pet owners regarding fatal diseases such as rabies are forcing them to vaccinate their dogs and cats on a regular basis. According to an article published by the World Organization for Animal Health (WOAH) in 2020, the transmission period of rabies in household dogs is between 3-7 days before the visualization of clinical symptoms. As the disease is said to have almost 100% mortality, pet owners are volunteering to vaccinate in order to protect their beloved animals.

Rabies poses a serious threat to animal health. It primarily affects livestock through bites from rabid dogs or other infected carnivorous species in wildlife. They are regarded as “dead-end” hosts since they cannot spread the infection. Since many developing nations have an endemic of rabies in livestock, the disease can be identified by clinical symptoms and a history of dog bites. Infected cattle may also pose a disease risk to farmers and veterinarians, which emphasizes the significance of adopting rabies control measures among livestock populations. Furthermore, companies that provide rabies vaccines for livestock animals, such as Zoetis and BroadChem Philippines Biopharma Corporation, are able to maintain a competitive market position. For instance, Zoetis supplies VANGUARD RABIES 1/3-year vaccine for cattle, whereas BroadChem Philippines Biopharma Corporation provides Biocan R vaccine for sheep, goats, pigs, and cattle. 

Country Insights

Thailand accounted for the maximum revenue share of more than 18.03% in 2022 owing to the successful implementation of mass vaccination programs and increased animal rabies vaccination coverage. Thailand has long been dedicated to eradicating rabies in accordance with the WHO, OIE, and FAO policy, called “Rabies-free South-East Asia by 2020.” The rabies management program was successful in bringing the number of annual human cases down from a few hundred in the 1960s to under ten between 2011 and 2015. However, in 2016, after the identification of a sudden surge in both animal and human rabies cases, a project called “The Strategies of Animals free of Rabies: Humans are Safe from the Disease, 2017-2020” was established. This rabies eradication program in Thailand achieved great goals.

Cambodia is anticipated to expand at the fastest CAGR over the forecast period owing to the country’s commitment to ‘rabies eradication by 2030’ programs and mass vaccination campaigns that recently gained traction in the country. The national rabies control plan, which has been approved by the Ministry of Health, was developed with assistance from the team at the Institut Pasteur in Cambodia. The current program does not call for routine dog vaccinations; instead, it is focused on enhancing surveillance, improving communication about prevention, acting in areas where rabies virus transmission aspects have been identified, and establishing frontline rabies prevention centers so that populations can be immunized under the necessary circumstances. Mission Rabies will return to Cambodia in May 2023 to build on their initial efforts and vaccinate the entire province of Phnom Penh. These factors are supporting the growth of the market.

Key Players

• Boehringer Ingelheim International GmbH
• Zoetis
• Merck & Co., Inc.
• Virbac
• Indian Immunologicals Ltd.
• BroadChem Philippines Biopharma Corporation 

Market Segmentation

• By Application Outlook
• Companion Animals
• Livestock Animals
• By Country Outlook
• Thailand
• Vietnam
• Cambodia
• Indonesia
• Laos
• Malaysia
• Philippines
• Myanmar
• Rest of ASEAN